accession	comparison	comparisonsText
GSE107363	1	HobRAvsHob
GSE85761	1	EVvsCells
GSE89179	1	siCon_FOB_ObvssiCon_FOB_Und
GSE89179	2	siCHD1_FOB_ObvssiCon_FOB_Ob
GSE89179	3	siCon_MSC_AdvssiCon_MSC_Und
GSE89179	4	siCon_MSC_ObvssiCon_MSC_Und
GSE89179	5	siCHD1_MSC_AdvssiCon_MSC_Ad
GSE89179	6	siCHD1_MSC_UndvssiCon_MSC_Und
GSE89179	7	siCHD1_MSC_ObvssiCon_MSC_Ob
22659600	1	OAvsNonOA
24361742	1	damagedvsundamaged
GSE72258	1	Rheumatoid.arthritis.synovial.fibroblast..HDAC1..25.nm.siRNA.knockdown..48.hvsRheumatoid.arthritis.synovial.fibroblast..NTC..25.nm.siRNA.knockdown..48.h
GSE72258	2	Rheumatoid.arthritis.synovial.fibroblast..C5orf30..50nm.siRNA..knockdown.24hvsRheumatoid.arthritis.synovial.fibroblast..NTC..50nm.siRNA..knockdown.24h
GSE69531	1	Plastic-PelletvsPlastic-Cell
GSE69531	2	ECM-PelletvsECM-Cell
GSE69531	3	ECM-PelletvsPlastic-Pellet
GSE69531	4	Plastic-PelletvsPlastic-Cell
GSE58203	1	IL1.1vsIL1.0
GSE58203	2	IL1.2vsIL1.0
GSE58203	3	IL1.4vsIL1.0
GSE58203	4	IL1.12vsIL1.0
GSE58203	5	PDGF.1vsPDGF.0
GSE58203	6	PDGF.2vsPDGF.0
GSE58203	7	PDGF.4vsPDGF.0
GSE58203	8	PDGF.12vsPDGF.0
GSE59642	1	osteoarthiritisvsreference
GSE59642	2	degenerated cartilagevsreference
GSE59642	3	degenerated cartilagevsosteoarthiritis
GSE64922	1	PlGF siRNAvscontrol siRNA
GSE60162	1	TBX5 overexpressionvsvector control
GSE31685	1	Interleukin.1beta.pre.stimulated.and.resveratrol.treatedvsNK..Interleukin.1beta.pre.stimulated
E-MEXP-3890	1	CD14-positive macrophagevsCD14-positive monocyte
GSE31980	1	MSC.aggregates.cultured.in.hanging.drop.culture.for.3.daysvsMSCs.in.a.monolayer.culture
GSE15615	1	TNFalphavsno cytokine
GSE15083	1	persistentvsextended
GSE108035	1	chondrocyte-like cells (ChiPS)vshuman induced pluripotent stem cells (GPCCi001-A)
GSE108035	2	chondrocyte-like cells (ChiPS)vschondrocyte cell line:  HC-402-05a
GSE108035	3	chondrocyte-like cells (ChiPS)vsprimary articular cartilage chondrocyte cell culture
GSE21959	1	HSF (healthy synovial fibroblasts) gene expression under hypoxic conditionsvsHSF (healthy synovial fibroblasts) gene expression under normoxic conditions
GSE21959	2	RASF (rheumatoid arthritis synovial fibroblasts) gene expression under hypoxic conditionsvsRASF (rheumatoid arthritis synovial fibroblasts) gene expression under normoxic conditions
GSE24742	1	EULAR Good-responder.12 weeks of RTX therapyvsEULAR Good-responder.baseline
GSE24742	2	EULAR Moderate-responder.12 weeks of RTX therapyvsEULAR Moderate-responder.baseline
GSE24742	3	EULAR Poor-responder.12 weeks of RTX therapyvsEULAR Poor-responder.baseline
GSE74668	1	treated with IL-17A _4hvsnon-treated control_4h
E-GEOD-57723	1	TNFvsnone
E-GEOD-57723	2	co-culture with fibroblastvsnone
E-GEOD-57723	3	TNF and co-culture with fibroblastvsnone
E-GEOD-83930	1	Pre-miR-17vsNC-Pre-miR
GSE100268	1	HPIP_KOvsControl
E-GEOD-10024	1	NDSF stimulated chondrocytesvsunstimulated chondrocytes
E-GEOD-10024	2	RASF stimulated chondrocytesvsunstimulated chondrocytes
E-GEOD-12860	1	RASF stimulated chondrocytesvsNDSF stimulated chondrocytes
E-GEOD-12860	2	Chondrocytes stimulated with prednisolone (solu-decortin) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	3	Chondrocytes stimulated with prioxicam treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	4	Chondrocytes stimulated with azathioprine (imurek) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	5	Chondrocytes stimulated with diclofenac treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	6	Chondrocytes stimulated with methylprednisolone (urbason) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	7	Chondrocytes stimulated with sodium aurothiomalate (tauredon) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	8	Chondrocytes stimulated with chloroquine phosphate (resochin) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-14359	1	conventional ostosarcoma tissuevsNon-neoplastic primary osteoblast cells with limited live span in vitro
E-GEOD-14359	2	metastatis tissuevsconventional ostosarcoma tissue
E-GEOD-1919	1	rheumatoid arthritis.disease modifying antirheumatic drugsvsrheumatoid arthritis.non-steroidal anti-inflammatory drugs
E-GEOD-1919	2	rheumatoid arthritis.steroids, disease modifying antirheumatic drugs and non-steroidal anti-inflammatory drugsvsrheumatoid arthritis.non-steroidal anti-inflammatory drugs
E-GEOD-1919	3	rheumatoid arthritis.steroids, disease modifying antirheumatic drugs and non-steroidal anti-inflammatory drugsvsrheumatoid arthritis.disease modifying antirheumatic drugs
E-GEOD-1919	4	rheumatoid arthritis.disease modifying antirheumatic drugsvsnormal.none
E-GEOD-1919	5	rheumatoid arthritis.steroids, disease modifying antirheumatic drugs and non-steroidal anti-inflammatory drugsvsnormal.none
E-GEOD-1919	6	rheumatoid arthritis.non-steroidal anti-inflammatory drugsvsnormal.none
E-GEOD-1919	7	osteoarthritis.non-steroidal anti-inflammatory drugsvsnormal.none
E-GEOD-1919	8	osteoarthritis.nonevsnormal.none
E-GEOD-1919	9	osteoarthritis.non-steroidal anti-inflammatory drugsvsosteoarthritis.none
E-GEOD-19664	1	Pooled_6_MSCs_d3vsPooled_5_MSCs_d0
E-GEOD-19664	2	Pooled_7_MSCs_d7vsPooled_5_MSCs_d0
E-GEOD-19664	3	Pooled_8_MSCs_d14vsPooled_5_MSCs_d0
E-GEOD-19664	4	Pooled_6_MSCs_d3vsPooled_5_MSCs_d0
E-GEOD-19664	5	Pooled_7_MSCs_d7vsPooled_6_MSCs_d3
E-GEOD-19664	6	Pooled_8_MSCs_d14vsPooled_7_MSCs_d7
E-GEOD-19664	7	Pooled_10_Chondros_d3vsPooled_9_Chondros_d0
E-GEOD-19664	8	Pooled_11_Chondros_d7vsPooled_10_Chondros_d3
E-GEOD-19664	9	Pooled_12_Chondros_d14vsPooled_11_Chondros_d7
E-GEOD-43923	1	osteophytic cartilagevsarticular cartilage
E-GEOD-51812	1	Chondrocyte_condensation_6wks_LCMvsArticular_chondrocytes_17wks
E-GEOD-51812	2	Remaining limb cells_6wks_LCMvsArticular_chondrocytes_17wks
E-GEOD-68760	1	X50.Âµg.ml.Galectin.1.for.24h.in.starvation.mediumvsuntreated
E-GEOD-82107	1	osteoarthritisvsHealthy control
E-GEOD-9451	1	chondrocytevsiliac
E-GEOD-9451	2	osteoblastvsiliac
E-GEOD-9451	3	fibroblastvsiliac
E-GEOD-9451	4	adipocytevsiliac
E-MEXP-2019	1	intermediate cell derived from dendritic cellsvsdendritic cell
E-MEXP-2019	2	osteoclast derived from dendritic cellsvsintermediate cell derived from dendritic cells
E-MEXP-2019	3	intermediate cell derived from monocytesvsmonocyte
E-MEXP-2019	4	osteoclast derived from monocytesvsintermediate cell derived from monocytes
E-MEXP-2276	1	thanatophoric dysplasiavsnormal
E-MEXP-2488	1	articular cartilagevsnucleus pulposus
E-MEXP-3129	1	X550vsX380
E-MEXP-3474	1	Kashin-beck diseasevsprimary osteoarthritis
E-MTAB-3010	1	DMEM-F12 + MIMIC miR450a-5pvsDMEM-F12
E-MTAB-3010	2	DMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 days + MIMIC miR28-5pvsDMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 days
E-MTAB-3010	3	DMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 daysvsDMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 2 days
E-MTAB-3010	4	DMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 21 daysvsDMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 days
E-MTAB-4152	1	direct co-culture with human umbilical vein endothelial cellsvsindirect co-culture with human umbilical vein endothelial cells
E-MTAB-4152	2	indirect co-culture with human umbilical vein endothelial cellsvsmonoculture
E-MTAB-4152	3	direct co-culture with human umbilical vein endothelial cellsvsmonoculture
GSE100609	1	normal - osteoporosis: Osteoporosisvsnormal - osteoporosis: Normal
GSE100786	1	Bone marrow Monocytes from RA patientvsBone marrow Monocytes from OA patient
GSE100786	2	Peripheral blood Monocytes from RA patientvsPeripheral blood Monocytes from OA patient
GSE103697	1	ARP-1.5 ug/ml CRP for 24 hoursvsARP-1.Control
GSE103697	2	MM.1S.5 ug/ml CRP for 24 hoursvsMM.1S.Control
GSE103697	3	U266.5 ug/ml CRP for 24 hoursvsU266.Control
GSE104113	1	chondrocyte.Adultvschondrocyte.Juvenile
GSE104113	2	Stem cells.Adultvschondrocyte.Juvenile
GSE104113	3	chondrocyte.Adultvschondrocyte.Juvenile
GSE10575	1	migratory cells only found in diseased OA tissue with stem cell characteristicsvshealthy chondrocytes
GSE10575	2	Osteocytes/-blasts in P2 from human bone chips of patients with OAvshealthy chondrocytes
GSE10575	3	T/C-28 cells (fetal human sternal chondrocytes, immortalized, M.Goldring)vshealthy chondrocytes
GSE13604	1	mesenchymal stem cells treated 8 hours with BMP6vsmesenchymal stem cells cultured 8 hours without BMP6
GSE13837	1	TGF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	2	TGF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	3	TGF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	4	TGF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	5	TGF stimulated synovial fibroblasts (1h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	6	TGF stimulated synovial fibroblasts (2h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	7	TGF stimulated synovial fibroblasts (4h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	8	TGF stimulated synovial fibroblasts (12h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	9	TGF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (1h).osteoarthritis
GSE13837	10	TGF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (2h).osteoarthritis
GSE13837	11	TGF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (4h).osteoarthritis
GSE13837	12	TGF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (12h).osteoarthritis
GSE13837	13	TNF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	14	TNF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	15	TNF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	16	TNF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	17	TNF stimulated synovial fibroblasts (1h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	18	TNF stimulated synovial fibroblasts (2h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	19	TNF stimulated synovial fibroblasts (4h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	20	TNF stimulated synovial fibroblasts (12h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	21	TNF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (1h).osteoarthritis
GSE13837	22	TNF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (2h).osteoarthritis
GSE13837	23	TNF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (4h).osteoarthritis
GSE13837	24	TNF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (12h).osteoarthritis
GSE16464	1	monolayer chondrocytes from OAvsmonolayer chondrocytes from normal
GSE16464	2	3D-cultured chondrocytes from OAvsmonolayer chondrocytes from OA
GSE19060	1	OAvsNormal
GSE27372	1	co-cultured with the JJN3 human myeloma cell linevscontrol
GSE27390	1	rheumatoid arthritisvsosteoarthritis
GSE29106	1	Measles Virus Nucleocapsid ProteinvsEmpty Vector
GSE29107	1	p62_wild_typevsp62_empty_vector
GSE29107	2	p62_P392Lvsp62_wild_type
GSE29745	1	Gene expression of human amnion infected 5 genesvsGene expression of human fetal re-differentiation chondrocytes
GSE29745	2	Gene expression of human adult re-differentiation chondrocytesvsGene expression of human fetal re-differentiation chondrocytes
GSE29745	3	Gene expression of human amnion infected 5 genesvsGene expression of human amnion
GSE35546	1	Kartogenin_1nM_6hvsDMSO
GSE35546	2	Kartogenin_10nM_6hvsDMSO
GSE35546	3	Kartogenin_100nM_6hvsDMSO
GSE35546	4	Kartogenin_1nM_24hvsDMSO
GSE35546	5	Kartogenin_10nM_24hvsDMSO
GSE35546	6	Kartogenin_100nM_24hvsDMSO
GSE35955	1	hMSC-old_elderlyvshMSC-C_middle-aged
GSE35956	1	diagnosis: primary osteoporosisvstissue: bone marrow
GSE35957	1	hMSC-senescentvshMSC-C_middle-aged
GSE35958	1	diagnosis: primary osteoporosisvstissue: bone marrow
GSE39340	1	ankylosing spondylitisvsrheumatoid arthritis
GSE39340	2	osteoarthritisvsrheumatoid arthritis
GSE39340	3	ankylosing spondylitisvsosteoarthritis
GSE39795	1	cartilage, middle zonevscartilage, deep zone
GSE39795	2	cartilage, superficial zonevscartilage, deep zone
GSE39795	3	cartilage, superficial zonevscartilage, middle zone
GSE41038	1	ankylosing spondylitisvsnormal control
GSE41038	2	seronegative spondyloarthropyvsnormal control
GSE41038	3	osteoarthritisvsnormal control
GSE41992	1	IL3vsnone
GSE42235	1	passage: 2vspassage: 0
GSE42235	2	passage: 4vspassage: 0
GSE42235	3	passage: 6vspassage: 0
GSE42235	4	passage: 8vspassage: 0
GSE45233	1	Knee meniscus, old, chondrosisvsKnee meniscus, young, chondrosis
GSE45233	2	Knee meniscus, old, chondrosisvsKnee meniscus, old, no chondrosis
GSE45233	3	Knee meniscus, young, chondrosisvsKnee meniscus, young, no chondrosis
GSE45233	4	Knee meniscus, old, no chondrosisvsKnee meniscus, young, no chondrosis
GSE46053	1	MSCs from healthy Donor cocultured with MM.1S cellsvsMSCs from healthy Donor cultured in solitary (i.e. no cocultured)
GSE46053	2	MSCs from MM patient cocultured with MM.1S cellsvsMSCs from healthy Donor cultured in solitary (i.e. no cocultured)
GSE46750	1	cultured.cells.from.synovial.membrane..inflammatoryvscultured.cells.from.synovial.membrane.normal.reactive
GSE51588	1	OA-Subchondral bone from medial tibialvsNormal-Subchondral bone from medial tibial
GSE51588	2	OA-Subchondral bone from lateral tibialvsNormal-Subchondral bone from lateral tibial
GSE51588	3	OA-Subchondral bone from medial tibialvsOA-Subchondral bone from lateral tibial
GSE52817	1	dOB (osteoblasts)vsgingival fibroblasts
GSE52817	2	dOB (osteoblasts)vsosteoblasts (OB)
GSE52817	3	dOB (osteoblasts)vsmesenchymal stem cells (MSC)
GSE52817	4	osteoblasts (OB)vsgingival fibroblasts
GSE55235	1	synovial tissue from rheumatoid arthritis jointvssynovial tissue from osteoarthritic joint
GSE55235	2	synovial tissue from rheumatoid arthritis jointvssynovial tissue from healthy joint
GSE55235	3	synovial tissue from osteoarthritic jointvssynovial tissue from healthy joint
GSE55457	1	rheumatoid arthritisvsosteoarthritis
GSE55457	2	rheumatoid arthritisvsnormal control
GSE55584	1	rheumatoid arthritisvsosteoarthritis
GSE57218	1	OAvsPreserved
GSE60762	1	OsteoarthriticvsHealthy
GSE62914	1	iPSC differentiated to chondrocyte for 4 daysvsiPSC
GSE62914	2	iPSC differentiated to chondrocyte for 9 daysvsiPSC
GSE62914	3	iPSC-derived chondrocytes (passage 3)vsiPSC
GSE62914	4	iPSC-derived chondrocytes (passage 3)vsadult chondrocyte
GSE64394	1	OA chondrocytesvsNormal chondrocytes
GSE66635	1	injured meniscusvsnormal articular cartilage
GSE68038	1	cartilage from knee (tibial plateau)vscartilage from proximal interphalangeal joint (PIP)
GSE68428	1	untreated + IL1vsuntreated
GSE68428	2	neg vehicle control + IL1vsuntreated
GSE68428	3	Lama4 + IL1vsuntreated
GSE69459	1	resFOP-iMSCs (+ActA)vsresFOP-iMSCs (-ActA)
GSE69459	2	FOP-iMSCs (+ActA)vsFOP-iMSCs (-ActA)
GSE69459	3	FOP-iMSCs (+ActA)vsresFOP-iMSCs (+ActA)
GSE69459	4	FOP-iMSCs (+ActA)vsresFOP-iMSCs (-ActA)
GSE69992	1	MSX1 siRNAvscontrol siRNA
GSE70719	1	fluoride (8 ppm) for 30 daysvsnone (untreated control)
GSE7116	1	Multiple Myeloma patient with osteonecrosis of the jawvsMultiple Myeloma patient on bisphosphonate therapy without osteonecrosis of the jaw
GSE7116	2	Multiple Myeloma patient with osteonecrosis of the jawvsHealthy volunteer
GSE7116	3	Multiple Myeloma patient on bisphosphonate therapy without osteonecrosis of the jawvsHealthy volunteer
GSE72575	1	IL-1Î²-stimulated in the presence of alloxanvsnon-stimulated
GSE72575	2	IL-1Î²-stimulated in the presence of GlcNvsnon-stimulated
GSE72575	3	IL-1Î²-stimulated in the presence of GlcN and alloxanvsnon-stimulated
GSE72575	4	IL-1Î²-stimulated MH7Avsnon-stimulated
GSE75181	1	cultured chondrocytes from cartilage_COTvscultured chondrocytes from cartilage_control
GSE75181	2	cultured chondrocytes from cartilage_ctrl_IL1Bvscultured chondrocytes from cartilage_control
GSE75181	3	cultured chondrocytes from cartilage_COT_IL1Bvscultured chondrocytes from cartilage_control
GSE75230	1	OIM treated, grow at 39oCvsuntreated, grow at 39oC in BM
GSE7669	1	fibroblasts_RAvsfibroblasts_OA
GSE77916	1	EPZ.5676.3.ÂµM.4.daysvsvehicle..DMSO..4.days
GSE80614	1	AD_1hrvsAD_0hr
GSE80614	2	AD_2hrvsAD_0hr
GSE80614	3	AD_05hrvsAD_0hr
GSE80614	4	AD_6hrvsAD_0hr
GSE80614	5	AD_12hrvsAD_0hr
GSE80614	6	AD_1dvsAD_0hr
GSE80614	7	AD_2dvsAD_0hr
GSE80614	8	AD_4dvsAD_0hr
GSE80614	9	OS_1hrvsOS_0hr
GSE80614	10	OS_2hrvsOS_0hr
GSE80614	11	OS_05hrvsOS_0hr
GSE80614	12	OS_6hrvsOS_0hr
GSE80614	13	OS_12hrvsOS_0hr
GSE80614	14	OS_1dvsOS_0hr
GSE80614	15	OS_2dvsOS_0hr
GSE80614	16	OS_4dvsOS_0hr
GSE85254	1	chondrocytes, Gal-3, 50 Âµg/mlvschondrocytes, untreated
GSE86578	1	IL.1.OSM.1vsnone (control).0
GSE86578	2	IL.1.OSM.1.25vsnone (control).0
GSE86578	3	IL.1.OSM.24vsnone (control).0
GSE9329	1	OsteoarthritisvsRhumatoid arthritis
GSE93698	1	diffuse systemic sclerosisvsMicrocrystalline arthritis
GSE93698	2	diffuse systemic sclerosisvsOsteoarthritis
GSE93698	3	diffuse systemic sclerosisvsRheumatoid arthritis
GSE93698	4	diffuse systemic sclerosisvsSeronegative arthritis
GSE93698	5	diffuse systemic sclerosisvsSystemic lupus erythematosus
GSE93698	6	Microcrystalline arthritisvsOsteoarthritis
GSE93698	7	Microcrystalline arthritisvsRheumatoid arthritis
GSE93698	8	Microcrystalline arthritisvsSeronegative arthritis
GSE93698	9	Microcrystalline arthritisvsSystemic lupus erythematosus
GSE93698	10	OsteoarthritisvsRheumatoid arthritis
GSE93698	11	OsteoarthritisvsSeronegative arthritis
GSE93698	12	OsteoarthritisvsSystemic lupus erythematosus
GSE93698	13	Rheumatoid arthritisvsSeronegative arthritis
GSE93698	14	Rheumatoid arthritisvsSystemic lupus erythematosus
GSE93698	15	Seronegative arthritisvsSystemic lupus erythematosus
E-GEOD-55769	1	Ad-NOER_E2vsAd-NOER
E-GEOD-55769	2	Ad-NERKI_E2vsAd-NERKI
E-GEOD-55769	3	Ad-Era_E2vsAd-Era
E-MTAB-4304	1	DamagedvsIntact
E-MTAB-4879	1	osteocyte_oldvsosteocyte_young
E-MTAB-4879	2	chondrocyte_oldvschondrocyte_young
E-MTAB-4879	3	tendon_oldvstendon_young
E-MTAB-4879	4	msc_oldvsmsc_young
E-MTAB-5564	1	osteoarthritisvsnormal
E-MTAB-6266	1	OAvsnonOA
GSE77753	1	EDS-HT/JHSvshealthy
GSE43861	1	Fibrogenesis imperfecta ossiumvscontrol
GSE112809	1	PBMC after 56 days of CPN10 treatmentvsPBMC at baseline
GSE111946	1	synthetic precursor miR-218vsscrambled control
GSE111946	2	inhibitors of miR-218vsAnti-miR Negative Control
E-MTAB-3201	1	psoriatic arthritis.synovial fluidvshealthy.synovial fluid
GSE54749	1	treated.with.Hh.inhibitorvsnone
GSE74220	1	IL1BvsControl
GSE114007	1	OAvsNonOA
GSE109503	1	Day21vsDay14
GSE109503	2	Day14vsDay7
GSE109503	3	Day7vsDay3
GSE109503	4	Day3vsDay1
GSE109503	5	Day1vsDay0
GSE109503	6	Day21vsDay0
GSE109503	7	Day14vsDay0
GSE109503	8	Day7vsDay0
GSE109503	9	Day3vsDay0
GSE109503	10	Day1vsDay0
GSE109108	1	mir138_day2vsNS_control_day2
GSE109108	2	mir138_day7vsNS_control_day7
GSE109108	3	mir181_day2vsNS_control_day2
GSE109108	4	mir181_day7vsNS_control_day7
GSE57218_B	1	OAvsHealthy
GSE57218_B	2	PreservedvsHealthy
GSE99662	1	HighvsLow
GSE73087	1	MSC-Day1 Induction-ApoA1vsMSC-Day1-Induction
GSE73087	2	MSC-Day3-Induction-ApoA1vsMSC-Day3-Induction
GSE73087	3	MSC-Day5-Induction-ApoA-1vsMSC-Day5-Induction
GSE121892	1	transfected.with.miR.320a.inhibitor..I.vstransfected.with.control.inhibitor..CI.
GSE121892	2	transfected.with.miR.320a.mimic..M.vstransfected.with.control.mimic..CM.
GSE114237	1	MG-63, mineralized bonevsMG-63, demineralized bone
GSE108771	1	Activinvscontrol
GSE108771	2	Activin + CP-724714vscontrol
GSE108771	3	Activin + Lapatinibvscontrol
GSE108771	4	Activin + TAKvscontrol
EGAD00001001331	1	OsteoarthritisvsNormal
GSE125167	1	Control_10_days_difvsControl_2_days_dif
GSE125167	2	Control_2_days_difvsNaiveControl
GSE125167	3	PLZF_10_days_diffvsPLZF_2_days_diff
GSE125167	4	PLZF_2_days_diffvsNaivePLZF
GSE125167	5	PLZF_10_days_diffvsControl_10_days_dif
GSE125167	6	PLZF_2_days_diffvsControl_2_days_dif
GSE125167	7	NaivePLZFvsNaiveControl
GSE80285	1	treated with 40ng/ml recombinant a-Klotho for 7 daysvsuntreated
GSE80285	2	transfected with siRNA against a-Klothovstransfected with siRNA control
OANOF	1	OAvsNOF
GSE70667	1	Flow_2hvsControl_2h
GSE87608	1	Runx2HET_vehiclevsWT_vehicle
GSE87608	2	WT_MS275vsWT_vehicle
GSE87608	3	Runx2HET_MS275vsRunx2HET_vehicle
GSE87608	4	Runx2HET_MS275vsWT_MS275
GSE90890	1	Cdc73fKOvsWT
GSE97118	1	WT_D7vsWT_D3
GSE97118	2	WT_D14vsWT_D7
GSE97118	3	Ezh2_cKO_D7vsEzh2_cKO_D3
GSE97118	4	Ezh2_cKO_D14vsEzh2_cKO_D7
GSE97118	5	Ezh2_cKO_D7vsWT_D7
GSE97118	6	Ezh2_cKO_D14vsWT_D14
GSE97118	7	Ezh2_cKO_D3vsWT_D3
GSE57740	1	shRNA specific for CHADLvsscrambled negative control shRNA
GSE52992	1	human TNF transgenic and knockout in Rsk2 gene (Rsk2-/y FLS)vshuman TNF transgenic without knockout (Rsk2+/y FLS)
GSE17160	1	Wild-type.LPS-treatedvsWild-type.none
GSE17160	2	Wild-type.HA-treatedvsWild-type.none
GSE17160	3	Wild-type.TSG6-treatedvsWild-type.none
GSE17160	4	Wild-type.TNFa-treatedvsWild-type.none
GSE17160	5	TSG-6 knockout.LPS-treatedvsTSG-6 knockout.none
GSE17160	6	TSG-6 knockout.HA-treatedvsTSG-6 knockout.none
GSE17160	7	TSG-6 knockout.TSG6-treatedvsTSG-6 knockout.none
GSE17160	8	TSG-6 knockout.TNFa-treatedvsTSG-6 knockout.none
GSE17160	9	TSG-6 knockout.LPS-treatedvsWild-type.LPS-treated
GSE17160	10	TSG-6 knockout.HA-treatedvsWild-type.HA-treated
GSE17160	11	TSG-6 knockout.TSG6-treatedvsWild-type.TSG6-treated
GSE17160	12	TSG-6 knockout.TNFa-treatedvsWild-type.TNFa-treated
GSE22971	1	MMP-8 KO control mousevsMMP-8 wild type control mouse
GSE22971	2	MMP-8 KO arthritic mousevsMMP-8 wild type arthritic mouse
GSE22971	3	MMP-8 wild type arthritic mousevsMMP-8 wild type control mouse
GSE22971	4	MMP-8 KO arthritic mousevsMMP-8 KO control mouse
GSE13590	1	siRNA-140vssiRNA-96
GSE13590	2	antimicroRNA-140vsantimicroRNA-449
GSE99731	1	DMM.1 wkvssham.1 wk
GSE99731	2	DMM.6 wkvssham.6 wk
GSE99731	3	DMM.6 wkvsDMM.1 wk
GSE27492	1	Ankle.D01vsAnkle.D00
GSE27492	2	Ankle.D03vsAnkle.D00
GSE27492	3	Ankle.D07vsAnkle.D00
GSE27492	4	Ankle.D12vsAnkle.D00
GSE27492	5	Ankle.D18vsAnkle.D00
GSE27492	6	Synovial fluid.D07vsSynovial fluid.D03
GSE27492	7	Synovial fluid.D12vsSynovial fluid.D03
GSE27492	8	Synovial fluid.D18vsSynovial fluid.D03
GSE107592	1	Adult CartilagevsEmbryonic Cartilage
GSE92641	1	Uhrf1KOvsControl
GSE107849	1	RORB_KOvsControl
E-GEOD-15069	1	LY294002-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
E-GEOD-15069	2	SB202190-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
E-GEOD-15069	3	TSA-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
E-GEOD-15069	4	UO126-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
E-GEOD-15118	1	The CH10T1/2 cell line transfected with the wild type PTHR1 treated with PTHrPvsThe CH10T1/2 cell line transfected with the wild type PTHR1
E-GEOD-15118	2	The CH10T1/2 cell line transfected with the R150C variant PTHR1 treated for one hour with PTHrPvsThe CH10T1/2 cell line transfected with the R150C variant PTHR1 treated with carrier
E-GEOD-15118	3	The CH10T1/2 cell line transfected with the R150C variant PTHR1 treated for one hour with PTHrPvsThe CH10T1/2 cell line transfected with the wild type PTHR1 treated with PTHrP
E-GEOD-15118	4	The CH10T1/2 cell line transfected with the R150C variant PTHR1 treated with carriervsThe CH10T1/2 cell line transfected with the wild type PTHR1
E-GEOD-16007	1	microRNA-140 depletionvscontrol
E-GEOD-17473	1	tissue: TMJ condyle; developmental stage: embryo; age: E16.5vstissue: TMJ fossa; developmental stage: embryo; age: E16.5
E-GEOD-18647	1	Cre.;Tgfbr2lox/wt.Intervertebral disc (IVD)vsCre.;Tgfbr2lox/lox.Intervertebral disc (IVD)
E-GEOD-18647	2	Cre.;Tgfbr2lox/wt.VertebraevsCre.;Tgrbr2lox.lox.Vertebrae
E-GEOD-18647	3	Cre.;Tgfbr2lox/wt.Intervertebral disc (IVD)vsCre.;Tgfbr2lox/wt.Vertebrae
E-GEOD-18647	4	Cre.;Tgfbr2lox/lox.Intervertebral disc (IVD)vsCre.;Tgrbr2lox.lox.Vertebrae
E-GEOD-18648	1	TGF.beta1vsnone
E-GEOD-18648	2	BMP4vsnone
E-GEOD-2154	1	X15vsX12
E-GEOD-2154	2	X12vsX9
E-GEOD-2154	3	X9vsX6
E-GEOD-2154	4	X6vsX3
E-GEOD-26475	1	Murine knee joint_Operated (DMM)_6hrvsMurine knee joint_Operated (Sham)_6hr
E-GEOD-26475	2	Murine knee joint_Operated (DMM)_3dayvsMurine knee joint_Operated (Sham)_3day
E-GEOD-26475	3	Murine knee joint_Operated (DMM)_7daysvsMurine knee joint_Operated (Sham)_7days
E-GEOD-33567	1	Mouse C2C12 cells (96h)vsMouse C2C12 cells (0h)
E-GEOD-33567	2	Mouse C2C12 cells treated with BMP2 (96h)vsMouse C2C12 cells (96h)
E-GEOD-37287	1	Interdigital Tissue Tbr2Prx1KO mutantsvsInterdigital Tissue Controls
E-GEOD-37287	2	Growth Plate Chondrocyte Tgfbr2Prx1KO  mutantsvsGrowth Plate Chondrocyte Controls
E-GEOD-37287	3	Interzone Tgfbr2Prx1KO mutantsvsInterzone Controls
E-GEOD-51994	1	SZvsMZ
E-GEOD-51994	2	SZvsDZ
E-GEOD-51994	3	MZvsDZ
E-GEOD-54216	1	superficial zonevsintermediate/deep zone
E-GEOD-54216	2	superficial zonevsresting zone
E-GEOD-54216	3	intermediate/deep zonevsresting zone
E-GEOD-6119	1	IL-1vscontrol
E-GEOD-6119	2	glucosaminevscontrol
E-GEOD-6119	3	IL-1 and glucosaminevscontrol
E-GEOD-65077	1	Over expression day 1 (vsControl day 1 (
E-GEOD-8077	1	contralateral osteoarthritis inductionvsipsilateral osteoarthritic induction
E-GEOD-8077	2	contralateral osteoarthritis inductionvssham surgery
E-GEOD-8077	3	ipsilateral osteoarthritic inductionvssham surgery
E-MEXP-1244	1	dexamethasonevsnone
E-MTAB-1123	1	wild type.12vswild type.6
E-MTAB-1123	2	mOL-AR knockout.12vsmOL-AR knockout.6
E-MTAB-1123	3	mOL-AR knockout.12vswild type.12
E-MTAB-1123	4	mOL-AR knockout.6vswild type.6
E-MTAB-1391	1	X27vsX9
E-MTAB-1391	2	X27vsX0
E-MTAB-1391	3	X9vsX0
E-MTAB-2450	1	control.rhBMP2vscontrol.none
E-MTAB-2450	2	miR-195 transfection.rhBMP2vsmiR-195 transfection.none
E-MTAB-2450	3	miR-195 transfection.rhBMP2vscontrol.rhBMP2
E-MTAB-2450	4	miR-195 transfection.nonevscontrol.none
E-MTAB-5023	1	Mesenchymal cell-specific homozygous deletion of SbdsvsSbds wildtype
E-MTAB-5326	1	25 MPa pressure.1vsno hydrostatic pressure.NA
E-MTAB-5326	2	25 MPa pressure.4vsno hydrostatic pressure.NA
E-MTAB-5326	3	25 MPa pressure.24vsno hydrostatic pressure.NA
GSE102588	1	X13del.tg.mutant.with.bone.overgrowthvswild.type
GSE103416	1	monosodium iodoacetate (MIA).2vsnaive.0
GSE103416	2	monosodium iodoacetate (MIA).14vsnaive.0
GSE103416	3	monosodium iodoacetate (MIA).28vsnaive.0
GSE104793	1	IL-1b treatedvsUntreated
GSE104794	1	Ad-Epas1(HIF-2a) infectedvsAd-null infected
GSE104795	1	Ad-Zip8 infectedvsAd-null infected
GSE105139	1	AhsgHETvsAhsgWT
GSE105139	2	AhsgKOvsAhsgWT
GSE105139	3	AhsgKOvsAhsgHET
GSE10555	1	osteoblast Slc39a13 knockoutvsosteoblast wild type
GSE10556	1	chondrocyte Slc39a13 knockoutvschondrocyte wild type
GSE106631	1	galectin-8 treated (50nM, 24hrs)vsnone
GSE13104	1	c2984, osteosarcoma from p53+/- mouse. Non-treated.vsCell type: mc3T3 mouse osteoblast, non-tumorigenic. Non-treated.
GSE13104	2	Osteosarcoma arisen from p53+/- mouse. Non-treated.vsCell type: mc3T3 mouse osteoblast, non-tumorigenic. Non-treated.
GSE13104	3	Rhabdomyosarcoma arisen from p53+/- mouse. Non-treated.vsCell type: mc3T3 mouse osteoblast, non-tumorigenic. Non-treated.
GSE16749	1	RAW 264.7, RANKL + M-CSFvsRAW 264.7, Unstimulated
GSE16749	2	RAW 264.7, Unstimulated, miR-155vsRAW 264.7, Unstimulated
GSE16749	3	RAW 264.7, RANKL + M-CSF, miR-155vsRAW 264.7, Unstimulated, miR-155
GSE17348	1	conditioned medium of MDA-PCa2b cellsvsconditioned medium of PC-3 cells
GSE17563	1	Differentiating precursorvsPrecursor
GSE17563	2	OsteoclastvsDifferentiating precursor
GSE17569	1	ALCAM(+) Sca-1(-)vsALCAM(-) Sca-1(-)
GSE17569	2	ALCAM(-) Sca-1(+)vsALCAM(-) Sca-1(-)
GSE17570	1	PDGFRa(+) Sca-1(+)vsPDGFRa(-) Sca-1(-)
GSE17570	2	PDGFRa(+) Sca-1(-)vsPDGFRa(-) Sca-1(-)
GSE18991	1	Hoxd4 transgenicvswild type
GSE18992	1	Hoxc8 transgenicvswild type
GSE19299	1	Rb KnockoutvsWild type
GSE19950	1	prothrombin adherent cells from long bonevsosteopontin adherent cells from long bone
GSE21093	1	RCCSvscontrol
GSE21523	1	TERC-/-vsTERC+/+
GSE21639	1	RAW_RL_day1vsRAW_CTRL_day1
GSE21639	2	RAW_RL_day2vsRAW_CTRL_day2
GSE21639	3	RAW_RL_day4vsRAW_CTRL_day4
GSE21639	4	RAW_RL_day5vsRAW_CTRL_day5
GSE21710	1	time: 24 hvstime: 0 h
GSE21710	2	time: 12 hvstime: 0 h
GSE21710	3	time: 6 hvstime: 0 h
GSE22925	1	Wild type mice, endothelial, G-CSFvsWild type mice, endothelial, untreated
GSE22925	2	Wild type mice, osteoblasts, G-CSFvsWild type mice, osteoblasts, untreated
GSE26499	1	RANKlowFmshighvsRANKhighFmslow
GSE30160	1	knockin mutantvswild type
GSE30322	1	subchondral bone,operation,1 week postsurgeryvssubchondral bone,sham operation,1 week postsurgery
GSE30322	2	subchondral bone,operation,2 weeks postsurgeryvssubchondral bone,sham operation,2 weeks postsurgery
GSE30322	3	subchondral bone,operation,4 weeks postsurgeryvssubchondral bone,sham operation,4 weeks postsurgery
GSE30628	1	Col10a1 p.Asn617Lysvswild type
GSE30628	2	ColXTgcogvswild type
GSE32163	1	del175k mutantvswild-type
GSE33656	1	Frzb -/-vswild-type
GSE33754	1	age: 8 weeks.strain: Str/ortvsage: 8 weeks.strain: CBA
GSE33754	2	age: 18 weeks.strain: Str/ortvsage: 18 weeks.strain: CBA
GSE33754	3	age: 40 weeks.strain: Str/ortvsage: 40 weeks.strain: CBA
GSE34570	1	osteoblasts_2uM PP1_24hrvsosteoblasts_DMSO_24hr
GSE35003	1	Ift88-deletedvswild-type
GSE35466	1	bone marrow cells, adiponectin, 4 hrsvsbone marrow cells, unterated, 4 hrs
GSE35466	2	bone marrow cells, adiponectin, 10 hrsvsbone marrow cells, unterated, 10 hrs
GSE35466	3	bone marrow cells, adiponectin, 24 hrsvsbone marrow cells, unterated, 24 hrs
GSE35466	4	bone marrow cells, adiponectin, 72 hrsvsbone marrow cells, unterated, 72 hrs
GSE35466	5	bone marrow cells, adiponectin, 120 hrsvsbone marrow cells, unterated, 120 hrs
GSE36925	1	BMP2(-),LOXL2(+)vsBMP2(-),LOXL2(-)
GSE36925	2	BMP2(+),LOXL2(-)vsBMP2(-),LOXL2(-)
GSE36925	3	BMP2(+),LOXL2(+)vsBMP2(-),LOXL2(-)
GSE37219	1	NFATc1 fl/fl MxCre+vsNFATc1 fl/fl MxCre-
GSE37676	1	Mc3T3 cells_treated with AA_5 daysvsMc3T3_untreated_5 days
GSE41342	1	Gene expression data from DMM joints 2 weeks after surgeryvsGene expression data from sham controls 2 weeks after surgery
GSE41342	2	Gene expression data from DMM joints 4 weeks after surgeryvsGene expression data from sham controls 4 weeks after surgery
GSE41342	3	Gene expression data from DMM joints 8 weeks after surgeryvsGene expression data from sham controls 8 weeks after surgery
GSE41342	4	Gene expression data from DMM joints 16 weeks after surgeryvsGene expression data from sham controls 16 weeks after surgery
GSE41997	1	Estrogen Receptor alpha knock-outvscontrol
GSE42295	1	surgery: OA.time after surgery: 2 weeksvssurgery: Sham.time after surgery: 2 weeks
GSE42295	2	surgery: OA.time after surgery: 8 weeksvssurgery: Sham.time after surgery: 8 weeks
GSE42295	3	surgery: OA.time after surgery: 8 weeksvssurgery: OA.time after surgery: 2 weeks
GSE43242	1	Osteoblast specific beta-catenin constitutively expressedvswild type
GSE43242	2	Osteoblast specific FoxO1 deletedvswild type
GSE43663	1	PG4P1vsWTP1
GSE43854	1	mutant (Gnptabc.3082insC)vswild-type
GSE45656	1	pre-osteoclastsvsMouse bone marrow macrophage
GSE45656	2	mature osteoclasts on platevspre-osteoclasts
GSE45656	3	mature resorbing osteoclasts on dentinvspre-osteoclasts
GSE45793	1	Adamts5Dcat DMM 6wkvsAdamts5Dcat Sham 6wk
GSE45793	2	Adamts5Dcat DMM 1wkvsAdamts5Dcat Sham 1wk
GSE45793	3	WT DMM 6wkvsWT Sham 6wk
GSE45793	4	WT DMM 2wkvsWT Sham 2wk
GSE45793	5	WT DMM 1wkvsWT Sham 1wk
GSE46390	1	CSF1vscontrol
GSE48438	1	Scl-tTA::TRE-BCR/ABLvsControl
GSE50549	1	SAHA2hrvsDMSO
GSE50549	2	SAHA6hrvsDMSO
GSE51098	1	Intermediate interzonevsouter interzone
GSE53857	1	X2.wks.post.surgery_treatedvsX2.wks.post.surgery_untreated
GSE53857	2	X4.wks.post.surgery_treatedvsX4.wks.post.surgery_untreated
GSE53857	3	X8.wks.post.surgery_treatedvsX8.wks.post.surgery_untreated
GSE53982	1	differentiating MC3T3-E1 cells treated with control scramble shRNAvsproliferating MC3T3-E1 cells treated with control scramble shRNA
GSE53982	2	differentiating MC3T3-E1 cells treated with Runx2-specific shRNAvsdifferentiating MC3T3-E1 cells treated with control scramble shRNA
GSE54779	1	Bone marrow monocytes treated with M-CSF and sRANKLvsBone marrow monocytes treated with M-CSF alone
GSE55900	1	Lrp5KOvsLrp5WT
GSE57104	1	Rs1 expressing osteoblastsvswild type osteoblasts
GSE59387	1	Dnmt3a knockoutvswild type
GSE60401	1	SXR_EtvsDsRed_Et
GSE60401	2	SXR_VK2vsDsRed_VK2
GSE60651	1	overexpressing A-CEBPvsoverexpressing GFP
GSE60737	1	overexpressing HES1vsoverexpressing GFP
GSE60761	1	genotype: wildtype.treatment: Calcitoninvsgenotype: wildtype.treatment: untreated
GSE60761	2	genotype: CalcrKO.treatment: Calcitoninvsgenotype: CalcrKO.treatment: untreated
GSE60761	3	genotype: CalcrKO.treatment: Calcitoninvsgenotype: wildtype.treatment: Calcitonin
GSE60761	4	genotype: CalcrKO.treatment: untreatedvsgenotype: wildtype.treatment: untreated
GSE63017	1	Pax1KOvsWT
GSE63017	2	Pax1HETvsWT
GSE63017	3	Pax1KOPax9KOvsWT
GSE63017	4	Pax1KOPax9HETvsWT
GSE63939	1	Osteoblastic in vitro differentiation of Kusa4b10 mouse cell line.vsKusa4b10 mouse cell line
GSE63939	2	Osteoblastic in vitro differentiation of Kusa4b10 mouse cell line.vsOsteosarcoma cell line
GSE64141	1	after 15 days of differentiation in chondrogenic mediavsprior to differentiation
GSE64965	1	X482.cells.Sox2shRNA.vsX482.cells.scrambledshRNA
GSE65745	1	X500.ng.ml.doxycyclinevsvehicle..control.
GSE65745	2	X10nM.E2vsvehicle..control.
GSE65745	3	X500.ng.ml.doxycycline.and.10nM.E2vsvehicle..control.
GSE66416	1	MC3T3-E1_over-expressing_periostinvsMC3T3-E1_empty_vector
GSE66554	1	newbornvsadult
GSE66554	2	youthvsadult
GSE66554	3	early-stage elderlyvsadult
GSE66554	4	latter-stage elderlyvsadult
GSE66862	1	Eed cKOvsWT
GSE69108	1	Nasal chondrocytevsRib Chondrocyte
GSE71565	1	differentiated for 12 daysvsdifferentiated for 5 days
GSE72261	1	Xbp1Cart{delta}Ex2 HZvsWt HZ
GSE72261	2	ColXN617K HZvsWt HZ
GSE72261	3	C/X HZvsWt HZ
GSE74898	1	cartilage, exercised for 2 daysvscartilage, control
GSE74898	2	cartilage, exercised for 5 daysvscartilage, control
GSE74898	3	cartilage, exercised for 15 daysvscartilage, control
GSE7683	1	DEX-treated embryonic primary chondrocyte cultures, incubated for 6vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 6
GSE7683	2	DEX-treated embryonic primary chondrocyte cultures, incubated for 24vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24
GSE78980	1	TO+/+ 1g no treatmentvsTO+/+ 0g no treatment
GSE78980	2	TO+/+ 1g treatedvsTO+/+ 1g no treatment
GSE78980	3	TO+/+ 0g treatedvsTO+/+ 0g no treatment
GSE78980	4	TO-/- 1g no treatmentvsTO-/- 0g no treatment
GSE78980	5	TO-/- 1g treatedvsTO-/- 1g no treatment
GSE78980	6	TO-/- 0g treatedvsTO-/- 0g no treatment
GSE78980	7	TO-/- 1g no treatmentvsTO+/+ 1g no treatment
GSE78980	8	TO-/- 0g no treatmentvsTO+/+ 0g no treatment
GSE78980	9	TO-/- 1g treatedvsTO+/+ 1g treated
GSE78980	10	TO-/- 0g treatedvsTO+/+ 0g treated
GSE79176	1	low (0.01mg/ml) concentration of polyphosphatesvsnone (control)
GSE79176	2	high (1mg/ml) concentration of polyphosphatesvsnone (control)
GSE79176	3	high (1mg/ml) concentration of polyphosphatesvslow (0.01mg/ml) concentration of polyphosphates
GSE81399	1	FACS sorted Dmp1-Cre targeted CAR cells from mouse bone marrowvsFACS sorted Dmp1-Cre non-targeted CAR cells from mouse bone marrow
GSE84609	1	X100.ng.ml.rGDF11vsVehicle.control
GSE84907	1	pH7.8vspH7.4
GSE84907	2	pH8.4vspH7.4
GSE84907	3	pH8.4vspH7.8
GSE85785	1	leptin-inducedvshealthy control
GSE90127	1	osteoblasts in differentiation medium and cabozantinib for 30 daysvsundifferentiated mouse osteoblasts
GSE90127	2	osteoblasts in differentiation medium and cabozantinib for 30 daysvsdifferentiated 30 day mouse osteoblasts
GSE90127	3	differentiated 30 day mouse osteoblastsvsundifferentiated mouse osteoblasts
GSE9247	1	MS-275 treated MC3T3 micevsDMSO treated MC3T3 mice
GSE9247	2	TSA treated MC3T3 micevsDMSO treated MC3T3 mice
GSE9247	3	VPA treated MC3T3 micevsDMSO treated MC3T3 mice
GSE99306	1	X13delChopKO_LHZvsWT_LHZ
GSE99306	2	X13delChopKO_LHZvsX13del_LHZ
GSE99306	3	X13del_LHZvsWT_LHZ
GSE99306	4	X13delChopKO_MHZvsX13del_MHZ
GSE99306	5	X13delChopKO_pHZvsWT_pHZ
GSE99306	6	X13delChopKO_pHZvsX13del_pHZ
GSE99306	7	X13del_pHZvsWT_pHZ
GSE99306	8	X13delChopKO_PZvsWT_PZ
GSE99306	9	X13delChopKO_PZvsX13del_PZ
GSE99306	10	X13del_PZvsWT_PZ
GSE99306	11	X13delChopKO_UHZvsWT_UHZ
GSE99306	12	X13delChopKO_UHZvsX13del_UHZ
GSE99306	13	X13del_UHZvsWT_UHZ
GSE99414	1	Il15ra nullvsCtrl
E-ERAD-89	1	MELATONIN_6vsDMSO_6
E-ERAD-89	2	MELATONIN_24vsDMSO_24
E-ERAD-89	3	SEROTONIN_24vsDMSO_24
E-ERAD-89	4	MELATONIN_48vsDMSO_48
E-GEOD-45893	1	Osr1MutvsOsr1WT
E-GEOD-53105	1	diaphysis_KOvsdiaphysis_WT
E-GEOD-53105	2	metaphysis_KOvsmetaphysis_WT
E-GEOD-54461	1	Day4vsDay2
E-GEOD-54461	2	Day6vsDay2
E-GEOD-54461	3	Day8vsDay2
E-GEOD-54461	4	Day10vsDay2
E-GEOD-54461	5	Day12vsDay2
E-GEOD-54461	6	Day14vsDay2
E-GEOD-54461	7	Day16vsDay2
E-GEOD-54461	8	Day18vsDay2
E-GEOD-73372	1	P1vsE18.5
E-GEOD-73372	2	P3vsE18.5
E-GEOD-73372	3	P3vsP1
E-GEOD-75549	1	hdac3KOvsWT
E-GEOD-76988	1	STAT5_cKOvsSTAT5_WT
E-MTAB-2923	1	osteoblastvsimmature_osteoblast
E-MTAB-2923	2	immature_osteoblastvsosteoprogenitor
E-MTAB-2923	3	osteoblastvsosteoprogenitor
E-MTAB-2923	4	osteoblastvsmesenchymal_stem_cell
E-MTAB-3428	1	KO-5AMvsWT-5AM
E-MTAB-3428	2	KO-5PMvsWT-5PM
E-MTAB-3428	3	KO-9AMvsWT-9AM
E-MTAB-3428	4	KO-9PMvsWT-9PM
GSE102856	1	Senp6-MutvsWT
GSE103492	1	WT_Wnt3avsWT
GSE103492	2	Lrp5KOvsWT
GSE103492	3	Lrp5KO_Wnt3avsWT
GSE103492	4	Lrp5KO_Wnt3avsLrp5KO
GSE103492	5	Lrp6_KOvsLrp6_Ctl
GSE103492	6	Lrp6KO_Wnt3avsLrp6_Ctl
GSE103492	7	Lrp6KO_Wnt3avsLrp6_KO
GSE103492	8	Lrp5_6_KOvsLrp5_6_Ctl
GSE103492	9	Lrp5_6_KO_Wnt3avsLrp5_6_Ctl
GSE103492	10	Lrp5_6_KO_Wnt3avsLrp5_6_KO
GSE106259	1	CCL5vsControl
GSE23492	1	Cell culture of isolated chondrocytes from growth plate cartilage, day 20 of differentiationvsNative growth plate cartilage
GSE23492	2	Cell culture of isolated chondrocytes from growth plate cartilage, day 10 of differentiationvsNative growth plate cartilage
GSE23492	3	Cell culture of isolated chondrocytes from articular cartilage, day 20 of differentiationvsNative articular cartilage
GSE23492	4	Cell culture of isolated chondrocytes from articular cartilage, day 10 of differentiationvsNative articular cartilage
GSE23492	5	Native articular cartilagevsNative growth plate cartilage
GSE44991	1	cartilage tissue from the condylus medialis femoris.affectedvscartilage tissue from the condylus medialis femoris.non-affected
GSE44991	2	cartilage tissue from the medial part of condylus humeri.affectedvscartilage tissue from the medial part of condylus humeri.non-affected
GSE39796	1	cartilage, superficial zonevscartilage, deep zone
GSE39796	2	cartilage, middle zonevscartilage, deep zone
GSE39796	3	cartilage, superficial zonevscartilage, middle zone
GSE18394	1	chondrocytes_day28vsMSC_day0
GSE18394	2	chondrocytes_day28vsMSC_day28
GSE18394	3	MSC_day28vsMSC_day0
GSE29233	1	TGFb treatedvsUntreated
E-MEXP-2291	1	nucleus pulposusvsarticular cartilage
E-MEXP-2291	2	annulus fibrosusvsarticular cartilage
E-MEXP-2291	3	nucleus pulposusvsannulus fibrosus
GSE110581	1	Zfp36l1 shRNA AdenovirusvsNull Control Adenovirus
GSE110581	2	Zfp36l1 AdenovirusvsNull Control Adenovirus
GSE47799	1	meniscusvsarticular cartilage
GSE47799	2	meniscusvscruciate ligament
GSE47799	3	cruciate ligamentvsarticular cartilage
E-MTAB-5879	1	Injury.Day7vsControl.Day0
E-MTAB-5879	2	Injury.Day28vsControl.Day0
E-MTAB-5879	3	InjuryReconstruct.Day7vsControl.Day0
E-MTAB-5879	4	InjuryReconstruct.Day28vsControl.Day0
E-MTAB-5879	5	InjuryRepair.Day7vsControl.Day0
E-MTAB-5879	6	InjuryRepair.Day28vsControl.Day0
E-MTAB-5879	7	InjuryRepair.Day28vsInjury.Day28
E-MTAB-5879	8	InjuryReconstruct.Day28vsInjury.Day28
E-MTAB-5879	9	InjuryRepair.Day7vsInjury.Day7
E-MTAB-5879	10	InjuryReconstruct.Day7vsInjury.Day7
E-MTAB-4294	1	synovitisvsControl
E-MTAB-4294	2	synovitis_with_corticosteroidvsControl
E-MTAB-4294	3	synovitis_with_corticosteroidvssynovitis
E-MTAB-3186	1	Day1vsControl
E-MTAB-3186	2	Day5vsControl
E-MTAB-3186	3	Day9vsControl
E-MTAB-3186	4	Day14vsControl
GSE110303	1	WT_PlbvsWT_E2
GSE110303	2	KO_PlbvsWT_Plb
GSE110303	3	KO_E2vsWT_E2
GSE110300	1	WT_PlbvsWT_E2
GSE110300	2	KO_PlbvsWT_Plb
GSE110300	3	KO_E2vsWT_E2
GSE110281	1	Sox9PosvsLrg5Pos
GSE110281	2	Sox9PosvsLrg5Neg
GSE110281	3	Lrg5PosvsLrg5Neg
GSE104459	1	E12.5_Pitx_KOvsE12.5WT
GSE104459	2	E11.5_Pitx_KOvsE11.5WT
GSE104459	3	E9.5_Pitx_KOvsE9.5WT
GSE110051	1	Mature_cartilagevsImmature_cartilage
GSE110051	2	BonevsMature_cartilage
GSE110051	3	BonevsImmature_cartilage
GSE111628	1	ovariectomizedvssham surgery
GSE111628	2	ovariectomized mice with treadmill trainingvsovariectomized
GSE111628	3	ovariectomized mice with treadmill trainingvssham surgery
GSE5657	1	Hyp malevsNormal male
GSE5657	2	Hyp femalevsNormal female
GSE13782	1	InflamedvsNormal
GSE41039	1	proteoglycan-induced spondylitisvsnone (Control)
GSE112694	1	Zfp384KO_3DayvsWT_3Days
GSE112694	2	Zfp384KO_7DayvsWT_7Days
GSE112694	3	WT_7DaysvsWT_3Days
GSE112694	4	Zfp384KO_7DayvsZfp384KO_3Day
GSE84198	1	Ezh2 KO proximal tibia PZvsWT proximal tibia PZ
GSE84198	2	Ezh2 KO proximal tibia HZvsWT proximal tibia HZ
GSE84198	3	WT proximal tibia PZvsWT proximal tibia HZ
GSE114469	1	Y1 deficient mousevsWT mouse
GSE108036	1	ANP32A KOvsWild.type
GSE97232	1	p21 misexpressionvsControl
GSE114079	1	SMAD3KO_E11.5vsWT_E11.5
GSE114079	2	SMAD3KO_E12.5vsWT_E12.5
GSE114079	3	SMAD3KO_E13.5vsWT_E13.5
GSE114079	4	SMAD3KO_E14.5vsWT_E14.5
GSE104828	1	Tet2KOvsWT
GSE114521	1	Sox9null_E11.5vsControl_E11.5
GSE114521	2	Sox9null_E12.5vsControl_E12.5
GSE112413	1	Mutant_SkullvsWT_Skull
GSE112413	2	WT_Cranial_BasevsWT_Skull
GSE101909	1	E14.5_Fgf8vsE14.5_Ctrl
GSE101909	2	E16.5_Fgf8vsE16.5_Ctrl
GSE114919	1	Phalanx_PZ_1wkvsPhalanx_HZ_1wk
GSE114919	2	Tibia_PZ_4wkvsTibia_PZ_1wk
GSE114919	3	Tibia_PZ_4wkvsTibia_HZ_4wk
GSE114919	4	Tibia_PZ_1wkvsTibia_HZ_1wk
GSE114919	5	Tibia_HZ_4wkvsTibia_HZ_1wk
GSE60451	1	TIMPlessvswild type
GSE47902	1	SHOX transgenevswildtype
GSE44325	1	Sost-/-; Sostdc1-/-vswild-type
GSE4481	1	R/P.CNP at 10exp(-6) MvsR/P.vehicle: BSA/HCL 1.0 Mm
GSE4481	2	H.CNP at 10exp(-6) MvsH.vehicle: BSA/HCL 1.0 Mm
GSE4481	3	M.CNP at 10exp(-6) MvsM.vehicle: BSA/HCL 1.0 Mm
GSE102292	1	15 daysvs12 days
GSE102292	2	12 daysvs9 days
GSE102292	3	9 daysvs6 days
GSE102292	4	6 daysvs2 days
GSE114919_Rat	1	Phalanx_PZ_1wkvsPhalanx_HZ_1wk
GSE114919_Rat	2	Tibia_PZ_4wkvsTibia_PZ_1wk
GSE114919_Rat	3	Tibia_PZ_4wkvsTibia_HZ_4wk
GSE114919_Rat	4	Tibia_PZ_1wkvsTibia_HZ_1wk
GSE114919_Rat	5	Tibia_HZ_4wkvsTibia_HZ_1wk
GSE41898	1	Lkb1 mutant micevscontrol mice
GSE18738	1	hypertrophic zonevsreserve zone
GSE87605	1	Hypertrophic cell layervsFlat cell layer
GSE87605	2	Flat cell layervsRound cell layer
GSE87605	3	Hypertrophic cell layervsRound cell layer
GSE16981	1	Hypertrophic zone.1 weekvsProliferative zone.1 week
GSE16981	2	Resting zone.1 weekvsProliferative zone.1 week
GSE16981	3	Hypertrophic zone.1 weekvsResting zone.1 week
GSE16981	4	Hypertrophic zone.1 weekvsResting zone.1 week
GSE16981	5	Proliferative and early hypertrophic zone.6weeksvsProliferative and early hypertrophic zone.3weeks
GSE16981	6	Proliferative and early hypertrophic zone.9weeksvsProliferative and early hypertrophic zone.6weeks
GSE16981	7	Proliferative and early hypertrophic zone.12weeksvsProliferative and early hypertrophic zone.9weeks
GSE29859	1	CorticalBone_ExcessVitAvsCorticalBone_Control
GSE29859	2	CorticalBone.Marrow_ExcessVitAvsCorticalBone.Marrow_Control
GSE121780	1	Apert syndrome_mandibular bonevscontrol_mandibular bone
GSE121780	2	Apert syndrome_Meckel's cartilagevscontrol_Meckel's cartilage
GSE121780	3	Apert syndrome_mandibular condylar cartilagevscontrol_mandibular condylar cartilage
GSE104473	1	Mandibular Distraction_10_BCSPvsMandibular Fracture_10_BCSP
GSE104473	2	Mandibular Distraction_10_OPvsMandibular Fracture_10_OP
GSE104473	3	Mandibular Distraction_10_SSCvsMandibular Fracture_10_SSC
GSE104473	4	Mandibular Distraction_15_BCSPvsMandibular Fracture_15_BCSP
GSE104473	5	Mandibular Distraction_15_OPvsMandibular Fracture_15_OP
GSE104473	6	Mandibular Fracture_15_SSCvsMandibular Distraction_15_SSC
GSE121033	1	Lentiviruses expressing LucvsNon surgery
GSE121033	2	Lentiviruses expressing PC2vsNon surgery
GSE108721	1	WT_RANKLvsWT_Basal
GSE108721	2	Mir182Loss_BasalvsWT_Basal
GSE108721	3	Mir182Gain_BasalvsWT_Basal
GSE108721	4	Mir182Loss_RANKLvsWT_RANKL
E-MTAB-6417	1	bone marrow.fracturevsbone marrow.none
E-MTAB-6417	2	periosteum.fracturevsperiosteum.none
E-MTAB-6417	3	periosteum.fracturevsbone marrow.fracture
E-MTAB-6417	4	periosteum.nonevsbone marrow.none
GSE120308	1	P5 Xbp1 KOvsP5 Xbp1 WT
GSE120308	2	P5 Xbp1 WT Matn3 MUTvsP5 Xbp1 KO Matn3 MUT
GSE120308	3	P5 Xbp1 KO Matn3 MUTvsP5 Xbp1 KO
GSE120308	4	P5 Xbp1 WT Matn3 MUTvsP5 Xbp1 WT
GSE115084	1	Flcn targeted siRNA transfectedvsscramble siRNA transfected
E-GEOD-8488	1	LYvsDMSO
E-GEOD-8488	2	UO126vsDMSO
E-GEOD-8488	3	SB90vsDMSO
E-GEOD-8488	4	TSAvsDMSO
E-MTAB-6857	1	FournucleivsTwonuclei
GSE112641	1	Injured_MRL_MpJ_1_day_post_injuryvsUninjured_MRL_MpJ_1_day_post_injury
GSE112641	2	Injured_C57BL_6_1_day_post_injuryvsUninjured_C57BL_6_1_day_post_injury
GSE112641	3	Injured_STR_ort_1_day_post_injuryvsUninjured_STR_ort_1_day_post_injury
GSE112641	4	Injured_MRL_MpJ_1_week_post_injuryvsUninjured_MRL_MpJ_1_week_post_injury
GSE112641	5	Injured_C57BL_6_1_week_post_injuryvsUninjured_C57BL_6_1_week_post_injury
GSE112641	6	Injured_STR_ort_1_week_post_injuryvsUninjured_STR_ort_1_week_post_injury
GSE112641	7	Injured_MRL_MpJ_2_weeks_post_injuryvsUninjured_MRL_MpJ_2_weeks_post_injury
GSE112641	8	Injured_C57BL_6_2_weeks_post_injuryvsUninjured_C57BL_6_2_weeks_post_injury
GSE112641	9	Injured_STR_ort_2_weeks_post_injuryvsUninjured_STR_ort_2_weeks_post_injury
GSE120244	1	Cre recombinasevsGFP
GSE121029	1	Lentiviruses expressing WT DGCR8vsLentiviruses expressing Luc
GSE121029	2	Lentiviruses expressing mtDRBD DGCR8vsLentiviruses expressing Luc
GSE123076	1	Adamts17-/-vswild type
GSE125153	1	Bcl3 knockout_1 dayvsWild-type_1 day
GSE125153	2	Bcl3 knockout_3 daysvsWild-type_3 days
GSE125153	3	Wild-type_3 daysvsWild-type_1 day
GSE125153	4	Bcl3 knockout_3 daysvsBcl3 knockout_1 day
GSE128402	1	Col2Cre; Adgrg6f/fvswild type
GSE7685	1	Manually.microdissected.embryonic.tibiae..zone.I.of.growth.platevsManually.microdissected.embryonic.tibiae..zone.II.of.growth.plate
GSE7685	2	Manually.microdissected.embryonic.tibiae..zone.II.of.growth.platevsManually.microdissected.embryonic.tibiae..zone.III.of.growth.plate
GSE7685	3	Manually.microdissected.embryonic.tibiae..zone.I.of.growth.platevsManually.microdissected.embryonic.tibiae..zone.III.of.growth.plate
GSE97828	1	MUTvsWT
GSE98295	1	miR-140 WT/G heterovsmiR-140 WT
GSE98295	2	miR-140 G/GvsmiR-140 WT
GSE98295	3	miR-140 KOvsmiR-140 WT
